Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Hubbard RA, Chubak J, Rutter CM. Estimating screening test utilization using electronic health records data. eGEMS. 2014 2(1). Article 14. doi: 10.13063/2327-9214.1109. PubMed
Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec;27(6):789-95. doi: 10.3122/jabfm.2014.06.140125. PubMed
Wang CY, Tapsoba JD, Anderson ML, Vernon SW, Chubak J, Fuller S, Green BB. Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1683-8. doi: 10.1158/1055-9965.EPI-14-0270. Epub 2014 Jun 2. PubMed
Green BB, Coronado GD. BeneFITs to increase colorectal cancer screening in priority populations. JAMA Intern Med. 2014 Aug;174(8):1242-3. doi: 10.1001/jamainternmed.2014.730. PubMed
Andersen MR, Thorpe J, Buist DS, Beatty JD, Watabayashi K, Hanson N, Resta R, Chubak J, Urban N. Cancer risk awareness and concern among women with a family history of breast or ovarian cancer. Behav Med. 2014 Jul 25:0 [Epub ahead of print]. PubMed
Murphy CC, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep;66:123-30. doi: 10.1016/j.ypmed.2014.06.013. Epub 2014 Jun 15. PubMed
Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner E. Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2014 Jun;8(2):229-38. doi: 10.1007/s11764-013-0335-1. Epub 2013 Dec 19. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.